- Home
- CVM vs SEED Comparison
CVM vs SEED Comparison
Compare CVM & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVM | SEED |
|---|---|---|
| Founded | 1983 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 15.9M |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CVM | SEED |
|---|---|---|
| Price | $1.66 | $1.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 153.6K | 22.9K |
| Earning Date | 05-13-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,033.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.45 | N/A |
| 52 Week Low | $0.23 | $0.82 |
| 52 Week High | $13.48 | $2.49 |
Technical Indicators
Market Signals| Indicator | CVM | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 24.76 | 52.42 |
| Support Level | N/A | $1.06 |
| Resistance Level | $4.84 | $1.35 |
| Average True Range (ATR) | 0.32 | 0.08 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 3.25 | 53.19 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.